ArticleCancers2025

Growth Hormone-Releasing Hormone (GHRH) Antagonist Peptides Combined with PI3K Isoform Inhibitors Enhance Cell Death in Prostate Cancer.

Carlos Perez-Stable et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.